Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Vildavas M 500mg/50mg Tablet

Prescription Icon
Prescription Required

Marketer

Cresha Lifesciences

Salt Composition

Metformin (500mg) + Vildagliptin (50mg)

Overview Vildavas M 500mg/50mg Tablet

Combiflex DM 500mg/50mg tablets combine two medications to manage elevated blood glucose in individuals with type 2 diabetes. This dual action helps mitigate serious diabetic complications like kidney failure and vision loss, potentially lowering the risk of cardiovascular events. Combiflex DM may be used independently or in conjunction with other antidiabetic therapies. Optimal efficacy requires adherence to a balanced diet and regular physical activity. Dosage is personalized based on individual health status, blood glucose readings, and concurrent medications. Consuming the tablets with food minimizes gastrointestinal discomfort. Consistent daily dosing at the same time maximizes therapeutic benefits; discontinuation should only occur under physician supervision. Effective blood sugar control reduces the likelihood of future complications. Maintaining the prescribed diet and exercise regime is crucial. Lifestyle significantly impacts diabetes management. Common side effects include diarrhea, nausea, vomiting, indigestion, headache, pharyngitis, fatigue, GERD, hyperhidrosis, and anorexia. Hypoglycemia is a potential adverse effect when used with insulin or sulfonylureas; appropriate recognition and management strategies are essential. This medication is not universally suitable. Prior to commencing treatment, inform your physician of any pre-existing kidney, liver, or heart conditions, pancreatic issues, or significant alcohol consumption. Pregnant or lactating women should seek medical advice. Interactions with other medications are possible; disclose all current medications to ensure safety. Alcohol should be minimized due to its potential to lower blood glucose. Your doctor will monitor kidney function and blood glucose levels throughout the treatment period.

Uses of Vildavas M 500mg/50mg Tablet

Managing Type 2 Diabetes

Major Benefits of Vildavas M 500mg/50mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Vildavas M 500mg/50mg Tablets should be administered with a meal.

Common Side effects of Vildavas M 500mg/50mg Tablet:

  • Hypoglycemia (low blood glucose level)
  • Trembling
  • Headache
  • Dizziness
  • Nausea
  • Weakness
  • Gastro-esophageal reflux disease
  • Increased sweating
  • Decreased appetite

How to use Vildavas M 500mg/50mg Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the 500mg/50mg Vildavas M tablet whole; avoid chewing, crushing, or fracturing it. It should be administered with a meal.

How Vildavas M 500mg/50mg Tablet works:

One tablet of Vildavas M contains 500mg of one antidiabetic medication and 50mg of another.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of alcohol and Vildavas M 500mg/50mg tablets is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

Pregnant individuals may experience adverse effects from Vildavas M 500mg/50mg Tablets. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the risks and benefits before prescribing this medication. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Vildavas M 500mg/50mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Caution is advised when administering Vildavas M 500mg/50mg Tablet to individuals with impaired renal function. Dosage modification may be necessary. Physician consultation is recommended.

LiverLiverUNSAFE

Patients with liver impairment should likely avoid Vildavas M 500mg/50mg Tablets due to potential safety concerns. A physician's consultation is advised.

What if you forget to take Vildavas M 500mg/50mg Tablet :

Should you forget a Vildavas M 500mg/50mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.

Facts to Know About Vildavas M 500mg/50mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Vildavas M 500mg/50mg Tablet

Vildavas M 500mg/50mg Tablet rarely causes hypoglycemia by itself; however, insufficient caloric intake while using it may lead to low blood sugar. Hypoglycemia symptoms include nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, and shakiness. These symptoms are more likely if you skip meals, drink alcohol, overexert yourself, or take other diabetes medications concurrently. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Nausea and vomiting are possible side effects of Vildavas M 500mg/50mg Tablet. If vomiting occurs, sip small amounts of water or other fluids frequently. Consult your doctor if vomiting continues or you experience dehydration symptoms such as dark, strong-smelling urine and infrequent urination. Always consult your doctor before taking any other medication.
Vildavas M 500mg/50mg Tablet is contraindicated in patients with allergies to its components or excipients. It should also not be used by those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Vildavas M 500mg/50mg Tablet combines the anti-diabetic medications metformin (a biguanide) and vildagliptin. Metformin reduces liver glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity. Vildagliptin, a DPP-4 inhibitor, boosts insulin release from the pancreas. This combination is contraindicated for individuals under 18.
Vildavas M 500mg/50mg Tablet can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare side effect necessitates avoiding the medication in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If experienced, discontinue Vildavas M 500mg/50mg Tablet and seek immediate medical attention.
Prolonged use of Vildavas M 500mg/50mg Tablet can lead to Vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia and neurological complications.
Vildavas M 500mg/50mg Tablet is safe when used as directed by your doctor. However, even with proper use, you may experience side effects such as nausea, diarrhea, vomiting, stomach upset, headache, nasal congestion, sore throat, respiratory infection, or low blood sugar (hypoglycemia, especially if also taking insulin or sulphonylurea). Report any persistent issues to your doctor.
Vildavas M 500mg/50mg Tab...
77
MRP 89
13% off